2m 2m 2m 2m 2m 2m 2m
QUINCE THERAP (QNCX)
NASDAQ
$1.02-$0.01 (-1.36%)
Price as of Jun 03, 2026 7:59 PM EDT- $22.5MMarket Cap
- -90.55%1-Year Change
- BiotechnologyIndustry
QUINCE THERAP (QNCX)
$1.02-$0.01 (-1.36%)
QNCX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.03 | ||
Change | -$0.02 (-1.90%) | ||
Open | $1.07 | ||
High | $1.07 | ||
Low | $1.00 | ||
Previous Close | $1.05 | ||
Volume | 1,110,965 | ||
30-Day Average Volume | 1,978,359 | ||
1-Week Change | -10.43% | ||
1-Month Change | -22.56% | ||
1-Year Change | -90.55% | ||
3-Year Change | -93.22% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 19.6M | ||
Total Assets | $26.6M | ||
Market Cap | $22.5M | ||
Enterprise Value | $4.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | $35.9M | ||
Free Cash Flow | -$7.6M | ||
EBIT | $30.6M | ||
EBITDA | $30.6M | ||
Net Working Capital | $16.8M | ||
EPS | $28.80 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | 0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/13/2026 | ||
Earnings & Revenue